These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 26807631

  • 1. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Jun; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 5. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.
    Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
    [Abstract] [Full Text] [Related]

  • 7. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 8. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Oct; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [Abstract] [Full Text] [Related]

  • 10. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
    Barayev E, Tiosano A, Zlatkin R, Elul R, Dotan A, Hadayer A, Gal-Or O, Ehrlich R.
    Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
    [Abstract] [Full Text] [Related]

  • 13. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 14. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

  • 15. Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.
    de Silva SR, Bindra MS.
    Eye (Lond); 2016 Jul; 30(7):952-7. PubMed ID: 27080482
    [Abstract] [Full Text] [Related]

  • 16. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A, Paez LR, Della Volpe Waizel M, Bisorca-Gassendorf L, Schulz A, Vandebroek AC, Szurman P, Januschowski K.
    PLoS One; 2021 Jul; 16(4):e0250587. PubMed ID: 33930041
    [Abstract] [Full Text] [Related]

  • 17. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F.
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [Abstract] [Full Text] [Related]

  • 18. Submacular hemorrhage in neovascular age-related macular degeneration: A synthesis of the literature.
    Stanescu-Segall D, Balta F, Jackson TL.
    Surv Ophthalmol; 2016 Apr; 61(1):18-32. PubMed ID: 26212151
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal injection of recombinant tissue plasminogen activator in submacular hemorrhage: case series.
    Araújo J, Sousa C, Faria PA, Carneiro Â, Rocha-Sousa A, Falcão-Reis F.
    Eur J Ophthalmol; 2016 Apr 12; 26(3):e49-51. PubMed ID: 26428222
    [Abstract] [Full Text] [Related]

  • 20. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F, Klatt C, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2010 Jan 12; 94(1):48-53. PubMed ID: 19946027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.